Hypercoagulability in celiac disease - An update

Aaron Lerner*, Miri Blank

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Abstract

Celiac disease is a life-long autoimmune disease affecting multiple organs of genetically susceptible individuals. One of the extra intestinal manifestations of the disease is thromboembolic events like strokes, veins' thrombosis, and pregnancy losses. Hypercoagulable autoimmune diseases like lupus erythematosus and antiphospholipid syndrome, associated with celiac disease just add risk to the patients. Pathogenic predisposing avenues increasing the hypercoagulability in celiac disease are multiple: nutritional deficiencies (B12, folate, and vitamin K), genetic predisposition (MTHFR mutations), thrombophilic autoantibodies, hyperhomocysinemia, endothelial dysfunction and platelet abnormalities. Primary pharmacologic thromboprophylaxis or treating the predisposing factors should be considered on a personal basis.

Original languageEnglish
Pages (from-to)1138-1141
Number of pages4
JournalAutoimmunity Reviews
Volume13
Issue number11
DOIs
StatePublished - 1 Nov 2014
Externally publishedYes

Keywords

  • Autoimmunity
  • Celiac disease
  • Hypercoagulability
  • Thromboembolism
  • Thrombophilia

Fingerprint

Dive into the research topics of 'Hypercoagulability in celiac disease - An update'. Together they form a unique fingerprint.

Cite this